Key result
ANP infusion reduces MAP by ~10% in both hypertensive and normotensive rats.
Why the study?
The differential haemodynamic effects of atrial natriuretic peptide in normotensive versus spontaneously hypertensive rats were not fully characterized.
Does atrial natriuretic peptide infusion have differential effects on central haemodynamic parameters in spontaneously hypertensive versus normotensive rats?
Does atrial natriuretic peptide infusion have differential effects on central haemodynamic parameters in spontaneously hypertensive versus normotensive rats?
Atrial natriuretic peptide reduces blood pressure in normotensive rats primarily via reduced cardiac output, whereas in hypertensive rats it also reduces total peripheral resistance.
Answers are grounded in this paper and cite their sources.
Supports differential haemodynamic effects of ANP; leaves open applicability to human hypertension.
Central haemodynamic parameters and cardiac performance were measured in conscious spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto (WKY) control rats after a 10-min infusion of rat ANP (103-125), 1 micrograms kg-1 min-1. Mean Arterial blood pressure (MAP) decreased by approximately 10% in both groups of rats. Heart rate (HR) increased slightly in both strains during the infusion. In the normotensive group the fall in MAP was due to a reduction in cardiac output (CO) while in the SHR there was a decrease in CO as well as in total peripheral resistance (TPR). The ANP infusion also reduced central blood volume (CBV) and stroke volume (SV) in both groups of rats. The reduction in CBV and CO was significantly more pronounced in the WKY strain. Left ventricular end diastolic pressure (LVEDP) and cardiac contractility (dP/dt) did not change while central venous pressure (CVP) was slightly decreased in the WKY group as a result of the ANP infusion. We conclude that ANP reduces MAP in normotensive animals by a reduction in CO. In the SHR a reduction in TPR also contributes to the fall in MAP. Atrial natriuretic peptide did not exert any negative inotropic effects, but the reduction of CO was due to an increased venous compliance.
No takes yet. Share an insight, caveat, or question.
Pettersson et al. (1988) studied Hypertension. rat ANP (103-125) vs. Normotensive Wistar Kyoto (WKY) control rats was evaluated on Mean Arterial blood pressure (MAP). Atrial natriuretic peptide infusion decreased mean arterial blood pressure by approximately 10% in both spontaneously hypertensive and normotensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: